Matches in Wikidata for { <http://www.wikidata.org/entity/Q63835070> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q63835070 description "clinical trial" @default.
- Q63835070 description "ensayu clínicu" @default.
- Q63835070 description "klinisch onderzoek" @default.
- Q63835070 description "клінічне випробування" @default.
- Q63835070 name "Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer" @default.
- Q63835070 type Item @default.
- Q63835070 label "Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer" @default.
- Q63835070 prefLabel "Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer" @default.
- Q63835070 P1132 Q63835070-48085A89-DEE3-44AB-B29C-98B9A812E751 @default.
- Q63835070 P131 Q63835070-1CC83939-08AF-4B4C-BDB7-58419567F0B5 @default.
- Q63835070 P1476 Q63835070-9870C3BB-F062-4E1C-B36D-1247C53156DA @default.
- Q63835070 P17 Q63835070-0DECC1B9-B05E-48CF-ABAD-E68228B9FDDE @default.
- Q63835070 P17 Q63835070-5BDAADF4-93A9-4178-B873-AF5008B00796 @default.
- Q63835070 P17 Q63835070-84159A4C-5094-4802-B81C-398D9FD74934 @default.
- Q63835070 P17 Q63835070-A87FB15F-E694-4463-8843-25E7A99D6B36 @default.
- Q63835070 P2899 Q63835070-9EAC8CDE-F4A7-4BE0-98E3-70B22D4ECE93 @default.
- Q63835070 P3098 Q63835070-37699741-0549-42D9-96B5-0CC5B91B022C @default.
- Q63835070 P31 Q63835070-5DAC1ABB-7A8A-4D36-8BBA-F84A0E608E7B @default.
- Q63835070 P580 Q63835070-1F866306-B5FA-4522-98AF-0783DDFE247B @default.
- Q63835070 P582 Q63835070-31DCA30F-98EB-4874-904F-B658377A5347 @default.
- Q63835070 P6099 Q63835070-84D74668-6247-4B6E-AC71-3D7AD75E85A6 @default.
- Q63835070 P8363 Q63835070-230B6CFE-4B16-449C-BD0C-5EC6082B6483 @default.
- Q63835070 P1132 "+123" @default.
- Q63835070 P131 Q8646 @default.
- Q63835070 P1476 "The Purpose of This Study is to Investigate Two Different Dose Regimens of Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-small Cell Lung Cancer." @default.
- Q63835070 P17 Q334 @default.
- Q63835070 P17 Q833 @default.
- Q63835070 P17 Q865 @default.
- Q63835070 P17 Q869 @default.
- Q63835070 P2899 "+18" @default.
- Q63835070 P3098 "NCT01104155" @default.
- Q63835070 P31 Q30612 @default.
- Q63835070 P580 "2010-02-24T00:00:00Z" @default.
- Q63835070 P582 "2011-04-07T00:00:00Z" @default.
- Q63835070 P6099 Q42824440 @default.
- Q63835070 P8363 Q78089383 @default.